| 2009 |
Acceptability of data generated from foreign clinical trials and ethnic factors in drug development; Geneva, Switzerland: 23 - 24 November 2009 |
Workshop Programme PDF
Workshop Report McAuslane N, Liberti L, Walker S, Connelly P. Emerging Markets: Acceptability of data generated from foreign clinical trials and ethnic factors in drug development. CMR International Institute for Regulatory Science, November 2009.
|
| |
Review and reimbursement: A special case for better cooperation; Surrey, UK: 29-30 September 2009 |
Workshop Programme PDF
Workshop Report Pichler F, Liberti L, Walker S, Connelly P. Review and reimbursement: A special case for better co-operation. CMR International Institute for Regulatory Science, September 2009.
Related Publication Liberti, Lawrence E.; Pichler, Franz; Walker, Stuart R. Preparing for regulatory review and reimbursement decisions: A case for cooperation between regulatory authorities, sponsors and health technology assessment agencies. Pharm Med.2009;23:263-267.
|
| |
Strategies for Communicating Benefit-Risk to Decision Makers: Explaining Methods, Findings and Conclusions Through a Common Approach Washington, DC, US: 17-19 June 2009 |
Workshop Programme PDF
Workshop Report PDF
Related Publication Liberti L, McAuslane N, Walker S. Progress on the development of a benefit/risk framework for the evaluation of medicines. Regulatory Focus Copyright 2010 by the Regulatory Affairs Professional Society (RAPS). Reprinted from the March 2010 issue of Regulatory Focus with the permission of RAPS.
|
| |
Expediting Patients' Access to Medicines: Solutions to Simultaneous Submissions and Approvals, Surrey, UK: 30-31 March 2009 |
Workshop Programme PDF
Workshop Report PDF
Related Publication Liberti L, Breckenridge A, Eichler H-G, Peterson, R, McAuslane N, Walker SR. Expediting Patients' Access to Medicines by Improving the Predictability of Drug Development and the Regulatory Approval Process. Clin Pharmacol Ther. 2010;87:27-31.
Workshop Synopsis PDF
|
| 2008 |
Clinical development in Asia, Africa and Latin America: Streamlining procedures for global clinical trial approval Singapore: December 2008 |
Workshop Report Walker S, McAuslane N, Cone M. Clinical development in Asia, Africa and Latin America: Streamlining the procedure for obtaining global clinical trial approvals. CMR International Institute for Regulatory Science, December, 2008.
|
| |
Predictable outcomes: Why do potential winners fail? 30 September to 1 October 2008 |
Workshop Report PDF
|
| |
Measuring Benefit and Balancing Risk: Strategies for the benefit-risk assessment of new medicines in a risk-averse environment Washington, DC, US: 19-20 June 2008 |
Workshop Report PDF
Related Publication Walker S, McAuslane N, Liberti L, Salek S. Measuring benefit and balancing risk: strategies for the benefit-risk assessment of new medicines in a risk-averse environment. Clin Pharmacol Ther. 2009;85:241-246.
|
| |
Knowledge Sharing and Cooperation: Are these the key to a more certain future for pharmaceutical innovation? Surrey, UK: 29-30 April 2008 |
Workshop Report PDF
|
| |
Regulation and Reimbursement: Two sides of the same coin Cobham, Surrey:16-17 January 2008 |
Workshop Report PDF
|
